The rising interest in GLP-1 agonists for diabetes has led to a question about delivery routes : transdermal systems versus capsules. Traditionally , GLP-1 therapies were only available in pill form, but https://nelsonvivb985346.blog-mall.com/41754240/glp-1-transdermal-delivery-systems-vs-tablets-which-right-for-individuals